Economic Burden of Irritable Bowel Syndrome
- 1 April 2000
- journal article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 17 (4), 331-338
- https://doi.org/10.2165/00019053-200017040-00003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonistAlimentary Pharmacology & Therapeutics, 1999
- The economic burden of irritable bowel syndrome in CanadaGastroenterology, 1998
- Irritable bowel syndrome: the view from general practiceEuropean Journal of Gastroenterology & Hepatology, 1997
- Successful practice in a managed care environment: Managing costs while managing careGastroenterology, 1996
- Medical costs in community subjects with irritable bowel syndromeGastroenterology, 1995
- drug development in gastroenterology—the changing view of industryAlimentary Pharmacology & Therapeutics, 1995
- Irritable Bowel Syndrome and Chronic Pelvic PainObstetrical & Gynecological Survey, 1994
- Irritable bowel-type symptoms in HMO examineesDigestive Diseases and Sciences, 1993
- U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 1993
- Towards positive diagnosis of the irritable bowel.BMJ, 1978